Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've landed here hoping to find a Mounjaro rebate, cashback scheme or discount programme for the UK, the short answer is that no such scheme exists for private patients in Britain. Mounjaro is a prescription-only medicine; its pricing in the UK is set by the manufacturer and dispensing pharmacies, and neither Eli Lilly nor legitimate UK pharmacies run rebate programmes for weight-management patients. What matters far more than chasing a rebate is knowing what a legitimate private prescription should and shouldn't include — and how to tell the difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Imagine you've done some research, spotted references to a Mounjaro savings card or rebate on a forum, and assumed something similar must exist in the UK. It's a reasonable assumption. In the United States, Eli Lilly has run manufacturer savings programmes that reduce the out-of-pocket cost for eligible patients. Those schemes operate within the US insurance and healthcare billing system; they have no equivalent here.
In the UK, Mounjaro is dispensed either through NHS channels (where eligible patients pay only the standard prescription charge or nothing at all) or privately, where pharmacies set their own prices. Eli Lilly UK does not publish a patient rebate or cashback arrangement for private weight-management prescriptions. If a website claims to offer a Mounjaro rebate, voucher or discount code for UK patients, that is worth treating with caution, see the MHRA's published guidance on reporting suspect sellers of weight-loss medicines.
The practical upshot: instead of hunting for a rebate, the more useful question is whether a given pharmacy's price is genuinely all-in. A question our prescribers hear most weeks, in various forms, is: "I found it cheaper elsewhere, is it the same thing?" The answer usually involves unpacking what the lower price does and doesn't include.
Mounjaro's UK list price rose substantially from September 2025, with widely reported figures suggesting the highest-dose pen moved from around £122 to around £330 per four-week supply at list price. Private pharmacies price above, at, or occasionally below that list depending on their cost base and margin, so the market range for private patients currently sits roughly between £149 and £375 per month depending on dose and provider.
Those figures, though, are only meaningful when you know what they include. Some providers quote the pen price alone and add a separate consultation fee, prescription charge and delivery cost. Others bundle everything. A low headline number that excludes clinical review isn't a saving; it's a gap in the service.
For context on what the full private cost landscape looks like, our Mounjaro price guide breaks down what UK patients typically pay and what those prices do and don't include. That transparency is easier to evaluate than a discount percentage attached to an unknown baseline.
The medicine itself must come through the licensed UK supply chain. Eli Lilly's authorised suppliers are the only legitimate source for genuine Mounjaro pens on this island. A price far below the market range is more likely to signal an unverified supply chain than a genuine commercial saving.
There's a version of the rebate search that is really about affordability, and that's entirely understandable. Weight-management treatment at private prices is a meaningful monthly expense, and wanting it to cost less is rational. The problem is that for a prescription medicine, cost-per-pen is the wrong axis to optimise on.
The right questions are: is this a genuine pen from an authorised source? Has a real clinician assessed whether it's appropriate for me at this dose? Is there someone I can contact if something goes wrong?
Mounjaro is a dual GIP and GLP-1 receptor agonist, the only medicine of its type licensed in the UK for weight management. The NHS tirzepatide page covers its side-effect profile and the situations that need clinical oversight. That oversight doesn't disappear because the pen arrived cheaply. It needs to be part of the service you're paying for.
At nume, a real prescriber, not an automated system, reads every consultation, and the price shown on our treatment page includes that clinical review, the prescription, and next-working-day tracked delivery. We don't offer rebates or discount codes because our pricing is designed to be transparent from the start, with nothing added at checkout. That's a different kind of value from a savings programme, but a more durable one.
If you'd like to understand more about how tirzepatide works or what the treatment journey looks like, our Mounjaro overview covers the clinical background, or you can explore tirzepatide's full profile for a more detailed look at the mechanism and evidence.
If you've come across a website, social media account or messaging service offering Mounjaro at a steep discount, with a rebate code, or without an upfront clinical consultation, pause before proceeding. The MHRA has confirmed that counterfeit weight-loss pens are in active circulation in the UK, some have contained insulin rather than tirzepatide, with serious consequences for patients who used them.
Legitimate online pharmacies are registered with the GPhC and can be verified directly at the GPhC pharmacy register. That verification takes about 30 seconds and is the single most reliable check available to patients. No registration number, no pharmacy.
Suspect sellers can and should be reported through the Yellow Card scheme. The MHRA takes these reports seriously and has used them to pursue enforcement action, including raids on illicit manufacturing sites. Reporting protects other patients, not just yourself.
If you have questions about timing, storage or what to do if a dose is delayed, our page on how late you can take Mounjaro addresses those practical concerns. And if you're curious about what results to realistically expect, the weight-loss rate page sets out the clinical trial evidence clearly, alongside our guide to Mounjaro use-by dates, which explains what to check before you inject each pen.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.